FDA 483 - Inventia Healthcare Limited - February 12, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Inventia Healthcare Limited, a drug manufacturer in Thane, Maharashtra, India, was cited for significant quality control and manufacturing deficiencies during an FDA inspection. Observations included a failure to thoroughly investigate numerous unexplained discrepancies, out-of-specification results, and customer complaints, as well as issues with equipment design and maintenance. The firm also demonstrated a lack of adequate quality control unit authority in reviewing production records and insufficient controls over computer systems.
ID · d7c622ff-4348-4477-8816-fbd606c6dfd1